Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

Related content
Volume 5, Number 2, July 2009

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
pp. 66-86(21)
Authors: Braccini, Laura; Morello, Fulvio; Perino, Alessia; Hirsch, Emilio

Favourites:Add to Favourites

Engineered Protein Protease Inhibitors
pp. 87-98(12)
Authors: Viswanathan, Malini; Comeau, Stephen R.; Ladner, Robert C.

Favourites:Add to Favourites

Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition
pp. 99-109(11)
Authors: Giansanti, V.; Dona, F.; Scovassi, A. I.

Favourites:Add to Favourites

Serine Protease Inhibitor Kazal Type 1 (SPINK1): Beyond the Trypsin Inhibitor
pp. 110-116(7)
Authors: Ohmuraya, Masaki; Ozaki, Nobuyuki; Hirota, Masahiko; Baba, Hideo; Yamamura, Ken-ichi

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more